CDC Influenza Pandemic OPLAN
Annex B - 11 July 2007
c. REPORTS AND PRODUCTS THAT CONTAIN DISEASE INTELLIGENCE
INFORMATION.
In the pandemic alert and pandemic periods, it will be critical for CDC decision-makers to have
immediate access to all available scientifically analyzed information about developing events including relevant peer reviewed scientific publications. Presenting timely and sound analysis will require utilization of a number of different intelligence products. Refer to Table 7 to Appendix 3 (Disease Intelligence Collection Plan).
1) Incident Action Plan (IAP):
The IAP is the primary incident management document and will normally cover a 24-hour
operational period, usually 1700-1700. The IAP will include all appropriate maps,
epidemiological graphs, synopses of media stories, etc. The IAP is intended to focus the
2) Director?s Morning Summary:
This daily briefing will draw from the Incident Action Plan covering a 24-hour period. The
briefing will be focused on updating the Director and CC Directors regarding the current
situation, objectives, planning assumptions, activities that have occurred and the most up-todate
information possible. Refer to Annex N (Reports and Products).
3) Afternoon Update Summary:
This briefing essentially mirrors the Director?s Morning Summary in format and purpose, but
will be concise and include only those developments that have occurred since the Director?s
Morning Summary briefing of which the Director and senior CDC policy makers need to be
aware and that require analysis. Refer to Annex N (Reports and Products).
4) Situation Reports:
Situation Reports will normally be prepared on a daily basis, at the end of the work day, or at
the same time each day, summarizing significant developments for quick reference of all
CDC personnel responding to a pandemic event. Normally these will not include detailed
analysis, but will be quick snapshots of key happenings. Refer to Annex N (Reports and
Products).
5) Spot Reports:
Spot reports will be submitted to the IM for approval before dissemination. Spot reports are
alerts to decision-makers regarding fast-breaking developments and would be issued on an
urgent basis during a pandemic crisis. Refer to Annex N (Reports and Products).
6) Executive Decision Support Briefs:
In substance, these briefs will be similar to individual items in the Director?s Morning
Summary, i.e., a description of a development in the event, accompanied by brief analysis.
These will be issued on an as-needed basis. Refer to Annex N (Reports and Products).
7) Executive Decision Support Memoranda:
These memoranda and products will serve the same general function as the Executive
Decision Support Brief, i.e., responding to an inquiry from a decision-maker or providing a
vehicle for an analyst to target information toward a specific executive audience. Refer to
Annex N (Reports and Products).
8) Long Term Analyses:
While these reports will also address breaking events in a pandemic, they will focus on
broader or longer term implications of the event. Their primary purpose will be to provide a
wider perspective to policy makers on fast-moving events. Refer to Annex N (Reports and
Products).
9) Travel Briefings:
OSEP will provide reports and briefings that will be comprehensive, all-source medical,
public health, and security assessments on specific countries for the purpose of informing
CDC staff being deployed abroad of the health and security situations they are likely to
encounter on arrival. OSEP will provide the personal security information, site situational
awareness, and respond to other requests for information, both classified and unclassified
events. Refer to Annex N (Reports and Products).
10) Media Updates:
These public health updates are designed to keep the general public apprised of the overall
health information situation. This public health information will be provided to media outlets,
including the internet. Refer to Annex N (Reports and Products).
11) Surveillance Data Reporting:
The Technical Specialty Unit within the IMS Planning Section will aggregate surveillance
data from State Epidemiologists and will report to the SA Section and other interested
parties. The SA Section will provide the latest epidemiological information for inclusion in
the IAP.
Refer to Annex N (Reports and Products).
Annex B - 11 July 2007
c. REPORTS AND PRODUCTS THAT CONTAIN DISEASE INTELLIGENCE
INFORMATION.
In the pandemic alert and pandemic periods, it will be critical for CDC decision-makers to have
immediate access to all available scientifically analyzed information about developing events including relevant peer reviewed scientific publications. Presenting timely and sound analysis will require utilization of a number of different intelligence products. Refer to Table 7 to Appendix 3 (Disease Intelligence Collection Plan).
1) Incident Action Plan (IAP):
The IAP is the primary incident management document and will normally cover a 24-hour
operational period, usually 1700-1700. The IAP will include all appropriate maps,
epidemiological graphs, synopses of media stories, etc. The IAP is intended to focus the
2) Director?s Morning Summary:
This daily briefing will draw from the Incident Action Plan covering a 24-hour period. The
briefing will be focused on updating the Director and CC Directors regarding the current
situation, objectives, planning assumptions, activities that have occurred and the most up-todate
information possible. Refer to Annex N (Reports and Products).
3) Afternoon Update Summary:
This briefing essentially mirrors the Director?s Morning Summary in format and purpose, but
will be concise and include only those developments that have occurred since the Director?s
Morning Summary briefing of which the Director and senior CDC policy makers need to be
aware and that require analysis. Refer to Annex N (Reports and Products).
4) Situation Reports:
Situation Reports will normally be prepared on a daily basis, at the end of the work day, or at
the same time each day, summarizing significant developments for quick reference of all
CDC personnel responding to a pandemic event. Normally these will not include detailed
analysis, but will be quick snapshots of key happenings. Refer to Annex N (Reports and
Products).
5) Spot Reports:
Spot reports will be submitted to the IM for approval before dissemination. Spot reports are
alerts to decision-makers regarding fast-breaking developments and would be issued on an
urgent basis during a pandemic crisis. Refer to Annex N (Reports and Products).
6) Executive Decision Support Briefs:
In substance, these briefs will be similar to individual items in the Director?s Morning
Summary, i.e., a description of a development in the event, accompanied by brief analysis.
These will be issued on an as-needed basis. Refer to Annex N (Reports and Products).
7) Executive Decision Support Memoranda:
These memoranda and products will serve the same general function as the Executive
Decision Support Brief, i.e., responding to an inquiry from a decision-maker or providing a
vehicle for an analyst to target information toward a specific executive audience. Refer to
Annex N (Reports and Products).
8) Long Term Analyses:
While these reports will also address breaking events in a pandemic, they will focus on
broader or longer term implications of the event. Their primary purpose will be to provide a
wider perspective to policy makers on fast-moving events. Refer to Annex N (Reports and
Products).
9) Travel Briefings:
OSEP will provide reports and briefings that will be comprehensive, all-source medical,
public health, and security assessments on specific countries for the purpose of informing
CDC staff being deployed abroad of the health and security situations they are likely to
encounter on arrival. OSEP will provide the personal security information, site situational
awareness, and respond to other requests for information, both classified and unclassified
events. Refer to Annex N (Reports and Products).
10) Media Updates:
These public health updates are designed to keep the general public apprised of the overall
health information situation. This public health information will be provided to media outlets,
including the internet. Refer to Annex N (Reports and Products).
11) Surveillance Data Reporting:
The Technical Specialty Unit within the IMS Planning Section will aggregate surveillance
data from State Epidemiologists and will report to the SA Section and other interested
parties. The SA Section will provide the latest epidemiological information for inclusion in
the IAP.
Refer to Annex N (Reports and Products).